Warning letter
La Vita Compounding Pharmacy, LLC: warning letter of Feb 28, 2019
FDA warning letter 575286 · Division of Pharmaceutical Quality Operations IV
Key facts
| Reference number | 575286 |
|---|---|
| Company | La Vita Compounding Pharmacy, LLC |
| Subject | Compounding Pharmacy/Adulterated Drug Products |
| Issue date | Feb 28, 2019 |
| Posted date | Mar 26, 2019 |
| Issuing office | Division of Pharmaceutical Quality Operations IV |
| Product type | Drugs |
| CFR sections cited | 201.115 |
| Inspection city | San Diego |
| Inspection ZIP | 92121-1436 |
| Inspection start date | Jun 4, 2018 |
| Letter on fda.gov | fda.gov |
At a glance
- 1–9 CFR sections cited
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: